AC092881.1 | HCG2014696 {ECO:0000313|EMBL:EAW97250.1}; PRO1454 {ECO:0000313|EMBL:AAG35485.1} | | | | | |
| | Tissue enhanced | 0 |
ADAM8 | ADAM metallopeptidase domain 8 | | | | |
|
| | Tissue enhanced | 0 |
AFF2 | AF4/FMR2 family, member 2 | | | | |
|
| | Tissue enhanced | 0 |
APOBEC3A | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | | | | |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
APOBEC3B | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B | | | | | |
| | Tissue enhanced | 0 |
ARG1 | Arginase 1 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
ARHGAP11B | Rho GTPase activating protein 11B | | | | | N/A |
| Vesicles | Tissue enhanced | 0 |
ARHGAP9 | Rho GTPase activating protein 9 | | | | |
|
| | Tissue enhanced | 0 |
ASTL | Astacin-like metallo-endopeptidase (M12 family) | | | | |
|
| | Tissue enhanced | 0 |
ATAD5 | ATPase family, AAA domain containing 5 | | | | | |
| | Tissue enhanced | 0 |
ATP8B4 | ATPase, class I, type 8B, member 4 | | | | |
|
| Nucleus but not nucleoli Vesicles | Tissue enhanced | 0 |
BCL2A1 | BCL2-related protein A1 | | | | | |
| | Tissue enhanced | 0 |
BIN2 | Bridging integrator 2 | | | | |
|
| | Tissue enhanced | 0 |
BRCA2 | Breast cancer 2, early onset | | | | | N/A |
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
C11orf21 | Chromosome 11 open reading frame 21 | | | | |
|
| | Tissue enhanced | 0 |
C16orf54 | Chromosome 16 open reading frame 54 | | | | | N/A |
| | Tissue enhanced | 0 |
C17orf53 | Chromosome 17 open reading frame 53 | | | | |
|
| Cytoplasm Nucleus but not nucleoli Plasma membrane | Tissue enhanced | 0 |
C19orf38 | Chromosome 19 open reading frame 38 | | | | |
|
| Cytoplasm Plasma membrane Golgi apparatus | Tissue enhanced | 0 |
C6orf25 | Chromosome 6 open reading frame 25 | | | | | |
| | Tissue enhanced | 0 |
CARD9 | Caspase recruitment domain family, member 9 | | | | |
|
| | Tissue enhanced | 0 |
CCL3 | Chemokine (C-C motif) ligand 3 | | | | | |
| | Tissue enhanced | 0 |
CCL4 | Chemokine (C-C motif) ligand 4 | | | | |
|
| | Tissue enhanced | 0 |
CCL4L1 | Chemokine (C-C motif) ligand 4-like 1 | | | | | |
| | Tissue enhanced | 0 |
CCNDBP1 | Cyclin D-type binding-protein 1 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
CCNE1 | Cyclin E1 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
CCNE2 | Cyclin E2 | | | | |
|
| | Tissue enhanced | 0 |
CCRN4L | CCR4 carbon catabolite repression 4-like (S. cerevisiae) | | | | |
|
| Nucleus Cytoplasm | Tissue enhanced | 0 |
CD300E | CD300e molecule | | | | |
|
| | Tissue enhanced | 0 |
CD69 | CD69 molecule | | | | |
|
| | Tissue enhanced | 0 |
CD83 | CD83 molecule | | | | |
|
| Vesicles | Tissue enhanced | 0 |
CDA | Cytidine deaminase | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
CDCA4 | Cell division cycle associated 4 | | | | |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
CDCA5 | Cell division cycle associated 5 | | | | |
|
| Nucleus but not nucleoli Plasma membrane | Tissue enhanced | 0 |
CEACAM21 | Carcinoembryonic antigen-related cell adhesion molecule 21 | | | | |
|
| | Tissue enhanced | 0 |
CENPU | Centromere protein U | | | | |
|
| Nucleus Microtubule organizing center | Tissue enhanced | 0 |
CFP | Complement factor properdin | | | | | |
| | Tissue enhanced | 0 |
CHI3L1 | Chitinase 3-like 1 (cartilage glycoprotein-39) | | | | | |
| | Tissue enhanced | 0 |
CKAP2L | Cytoskeleton associated protein 2-like | | | | |
|
| Nucleus but not nucleoli Plasma membrane Vesicles | Tissue enhanced | 0 |
CLDN9 | Claudin 9 | | | | |
|
| | Tissue enhanced | 0 |
CLEC12A | C-type lectin domain family 12, member A | | | | |
|
| | Tissue enhanced | 0 |
CLEC4E | C-type lectin domain family 4, member E | | | | | N/A |
| Cytoplasm | Tissue enhanced | 0 |
CLEC7A | C-type lectin domain family 7, member A | | | | |
|
| Nucleus but not nucleoli Vesicles | Tissue enhanced | 0 |
CNTF | Ciliary neurotrophic factor | | | | |
|
| Vesicles | Tissue enhanced | 0 |
CR1L | Complement component (3b/4b) receptor 1-like | | | | |
|
| | Tissue enhanced | 0 |
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | | | | |
|
| | Tissue enhanced | 0 |
CSNK2B-LY6G5B-1181 | Chimera CSNK2B-LY6G5B splicing isoform 1181 {ECO:0000313|EMBL:CCI79697.1}; Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000365040} | | | | |
|
| | Tissue enhanced | 0 |
CTD-3214H19.16 | | | | | | |
| | Tissue enhanced | 0 |
CTSW | Cathepsin W | | | | |
|
| | Tissue enhanced | 0 |
CYP4F3 | Cytochrome P450, family 4, subfamily F, polypeptide 3 | | | | |
|
| | Tissue enhanced | 0 |
DOK3 | Docking protein 3 | | | | | |
| | Tissue enhanced | 0 |